Skip to main content

Table 2 Mean values of baseline levels for both HCV RNA (IU/ml) and HCVcAg (Peiu/ml) assays among the studied groups

From: Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

Studied groups Baseline levels
HCV RNA serum level (IU/ml) Kruskal-Wallis test P value Post hoc test HCVcAg serum level (Peiu/ml) ANOVA test and P value Post hoc test
Mean ± SD Mean ± SD
Group I (n = 140) 95648.1 ± 50814.0 Test = 22.76
P < 0.001**
P1 < 0.001**
P2 = 0.001**
P3 = 0.002*
1.4 ± 0.35 Test = 69.69
P < 0.001**
P1 = 0.002*
P2 < 0.001**
P3 < 0.001**
Group II (n = 80) 1082313.0 ± 558186.7 2.6 ± 0.68
Group III (n = 60) 4812067.8 ± 1837006.9 5.9 ± 1.5
  1. *Significant
  2. **Highly significant